Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Pihlajalinna Oyj (PIHLIS.HE)
EUR10.40
-0.22 (-2.07%)
FI HEL Healthcare Medical - Care Facilities
Address
Kehräsaari 33200
Tampere, FI
Tampere, FI
CEO
Tuomas Hyyryläinen
Website
pihlajalinna.fi
IPO
2015-06-04
ISIN FI4000092556
Description
Pihlajalinna Oyj provides social, healthcare, and wellbeing services to private persons, companies, insurance companies, and public sector entities in Finland. It operates in two segments, Private Healthcare Services and Public Services. The company offers general practitioner and medical specialist, occupational healthcare, social and healthcare outsourcing, fitness center, responsible doctor, and remote consultation services, as well as residential and staffing services. It also provides occupational health services to private clinics and hospitals, responsible doctor, diagnostics, and rehabilitation services. The company was founded in 2014 and is headquartered in Tampere, Finland.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR10.40
-0.22 (-2.07%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
20.3K
Beta
0.14
Float Shares
17.46M
Free Float %
77.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.74% | -0.92% | -3.93% | -19.40% | -24.49% | -25.79% | -25.28% | +14.47% | -1.28% | -39.31% | -6.43% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
10.40
DCF (Unlevered)
705.57
+6,684.3%
DCF (Levered)
441.56
+4,145.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 1 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.71
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-7.4% Q1'26: -21.7% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+47.8% ★ Q1'26: -24.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+9.1% Q1'26: +7.1% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+9.1% Q1'26: +8.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+11.2% ★ Q1'26: +8.7% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.76× Q1'26: 3.08× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
213.33M
est: 219.90M (-3.0%)
|
399.09M
est: 397.86M (+0.3%)
|
423.98M
est: 428.17M (-1.0%)
|
487.76M
est: 482.79M (+1.0%)
|
518.60M
est: 518.80M (0.0%)
|
508.68M
est: 506.81M (+0.4%)
|
577.77M
est: 575.49M (+0.4%)
|
690.48M
est: 681.03M (+1.4%)
|
720.00M
est: 705.72M (+2.0%)
|
704.40M
est: 703.50M (+0.1%)
|
652.30M
est: 655.94M (-0.6%)
|
578.03M
569.75M – 584.59M
-11.9% YoY
|
606.58M
587.13M – 621.66M
+4.9% YoY
|
626.21M
626.07M – 626.35M
+3.2% YoY
|
620.72M
606.19M – 632.07M
-0.9% YoY
|
| EBITDA |
11.48M
est: 23.19M (-50.5%)
|
27.35M
est: 41.96M (-34.8%)
|
33.18M
est: 45.15M (-26.5%)
|
44.39M
est: 50.91M (-12.8%)
|
43.98M
est: 54.71M (-19.6%)
|
50.86M
est: 53.45M (-4.8%)
|
61.40M
est: 60.69M (+1.2%)
|
54.21M
est: 71.82M (-24.5%)
|
70.99M
est: 178.14M (-60.2%)
|
101.40M
est: 177.58M (-42.9%)
|
109.20M
est: 165.57M (-34.0%)
|
145.91M
143.82M – 147.56M
-11.9% YoY
|
153.11M
148.20M – 156.92M
+4.9% YoY
|
158.07M
158.03M – 158.10M
+3.2% YoY
|
156.68M
153.01M – 159.55M
-0.9% YoY
|
| EBIT |
3.05M
est: 8.44M (-63.8%)
|
15.06M
est: 15.27M (-1.4%)
|
19.00M
est: 16.44M (+15.6%)
|
12.85M
est: 18.53M (-30.7%)
|
10.31M
est: 19.91M (-48.2%)
|
17.77M
est: 19.45M (-8.7%)
|
27.65M
est: 22.09M (+25.2%)
|
8.38M
est: 26.14M (-67.9%)
|
19.10M
est: 110.20M (-82.7%)
|
48.40M
est: 109.85M (-55.9%)
|
59.20M
est: 102.43M (-42.2%)
|
90.26M
88.97M – 91.29M
-11.9% YoY
|
94.72M
91.68M – 97.07M
+4.9% YoY
|
97.78M
97.76M – 97.81M
+3.2% YoY
|
96.93M
94.66M – 98.70M
-0.9% YoY
|
| Net Income |
464.0K
est: 1.86M (-75.0%)
|
8.05M
est: 10.58M (-23.9%)
|
9.52M
est: 12.56M (-24.3%)
|
3.83M
est: 5.61M (-31.8%)
|
3.37M
est: 12.66M (-73.4%)
|
8.69M
est: 9.48M (-8.4%)
|
20.10M
est: 22.73M (-11.6%)
|
9.52M
est: 18.37M (-48.2%)
|
5.73M
est: 10.33M (-44.5%)
|
27.36M
est: 25.09M (+9.0%)
|
37.60M
est: 38.55M (-2.5%)
|
27.59M
26.93M – 29.30M
-28.4% YoY
|
34.78M
33.52M – 38.27M
+26.1% YoY
|
38.83M
36.04M – 41.86M
+11.6% YoY
|
39.80M
38.58M – 40.74M
+2.5% YoY
|
| SGA |
3.29M
est: 2.28M (+44.2%)
|
4.83M
est: 4.12M (+17.2%)
|
5.62M
est: 4.43M (+26.8%)
|
7.62M
est: 5.00M (+52.5%)
|
8.05M
est: 5.37M (+49.8%)
|
6.07M
est: 5.25M (+15.6%)
|
7.83M
est: 5.96M (+31.4%)
|
6.44M
est: 7.05M (-8.7%)
|
6.80M
est: 6.73M (+1.0%)
|
5.31M
est: 6.71M (-20.9%)
|
5.10M
est: 6.25M (-18.5%)
|
5.51M
5.43M – 5.57M
-11.9% YoY
|
5.78M
5.60M – 5.93M
+4.9% YoY
|
5.97M
5.97M – 5.97M
+3.2% YoY
|
5.92M
5.78M – 6.03M
-0.9% YoY
|
| EPS |
0.03
est: 0.08 (-63.6%)
|
0.39
est: 0.47 (-17.0%)
|
0.46
est: 0.56 (-17.6%)
|
0.17
est: 0.25 (-31.8%)
|
0.15
est: 0.56 (-73.3%)
|
0.38
est: 0.42 (-9.8%)
|
0.89
est: 1.01 (-11.9%)
|
0.42
est: 0.82 (-48.5%)
|
0.19
est: 0.46 (-58.5%)
|
1.13
est: 1.12 (+1.0%)
|
1.67
est: 1.72 (-2.8%)
|
1.26
1.20 – 1.30
-26.6% YoY
|
1.56
1.49 – 1.70
+23.9% YoY
|
1.71
1.60 – 1.86
+9.6% YoY
|
1.77
1.71 – 1.81
+3.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
14.44M
OE per share TTM
0.64
Owner's Yield
5.97%
Maintenance CapEx ratio
215.94%
Maint CapEx / Avg PPE
33.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 11 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L | 0.08% | 72.8K | 0.38% |
| 2 | WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE | 0.08% | 72.8K | 0.38% |
| 3 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.03% | 147.6K | 0.48% |
| 4 | WisdomTree International SmallCap Dividend Fund DLS | 0.03% | 315.6K | 0.58% |
| 5 | Dimensional - International Vector Equity ETF DXIV | 0.01% | 12.6K | 0.53% |
| 6 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 169.6K | 0.28% |
| 7 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 187.9K | 0.22% |
| 8 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | 11.1K | 0.24% |
| 9 | Dimensional - International Small Cap Value ETF DISV | 0.00% | 31.8K | 0.42% |
| 10 | Dimensional - International Small Cap ETF DFIS | 0.00% | 29.7K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
13.0K
Shares Outstanding
22.48M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Tuomas Risto-Matias Hyyrylainen | President & CEO | 540.0K | male |
| Heikki Tarkkila | Chief Commercial Officer | — | male |
| Jaakko Liljeroos | Executive Vice President, Chief Legal Officer & Secretary of the Board | — | male |
| Lauri Muhonen | Executive Vice President & Chief Information Officer | — | male |
| Mika Vidi Videman | Executive Vice President of People & Culture | — | male |
| Sari Riihijarvi | Executive Vice President & Chief Medical Officer | — | female |
| Seppo Kariniemi | Executive Vice President of Healthcare services | — | male |
| Tarja Kristiina E. Rantala | Chief Financial Officer | — | female |
| Heikki Farkkila | Executive Vice President of Strategy & Group Operations | — | male |
| Tuula Lehto | Executive VP of Communications, Marketing and Sustainability | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PIHLIS.HE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
